BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28714184)

  • 1. Research Review: What have we learned about adolescent substance use?
    Gray KM; Squeglia LM
    J Child Psychol Psychiatry; 2018 Jun; 59(6):618-627. PubMed ID: 28714184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of adolescent substance use disorders: implications for prevention and treatment.
    Rutherford HJ; Mayes LC; Potenza MN
    Child Adolesc Psychiatr Clin N Am; 2010 Jul; 19(3):479-92. PubMed ID: 20682216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders.
    Nock NL; Minnes S; Alberts JL
    Birth Defects Res; 2017 Dec; 109(20):1711-1729. PubMed ID: 29251846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing the critical health problem of adolescent substance use through health care, research, and public policy.
    Feinstein EC; Richter L; Foster SE
    J Adolesc Health; 2012 May; 50(5):431-6. PubMed ID: 22525104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cluster-randomized controlled trial evaluating the effects of delaying onset of adolescent substance abuse on cognitive development and addiction following a selective, personality-targeted intervention programme: the Co-Venture trial.
    O'Leary-Barrett M; Mâsse B; Pihl RO; Stewart SH; Séguin JR; Conrod PJ
    Addiction; 2017 Oct; 112(10):1871-1881. PubMed ID: 28544009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and brief intervention for alcohol and other abuse.
    Harris SK; Louis-Jacques J; Knight JR
    Adolesc Med State Art Rev; 2014 Apr; 25(1):126-56. PubMed ID: 25022191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiology of adolescent substance use and addictive behaviors: treatment implications.
    Hammond CJ; Mayes LC; Potenza MN
    Adolesc Med State Art Rev; 2014 Apr; 25(1):15-32. PubMed ID: 25022184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance-use in Childhood and Adolescence: A Brief Overview of Developmental Processes and their Clinical Implications.
    Castellanos-Ryan N; O'Leary-Barrett M; Conrod PJ
    J Can Acad Child Adolesc Psychiatry; 2013 Feb; 22(1):41-6. PubMed ID: 23390432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief school-based interventions and behavioural outcomes for substance-using adolescents.
    Carney T; Myers BJ; Louw J; Okwundu CI
    Cochrane Database Syst Rev; 2014 Feb; (2):CD008969. PubMed ID: 24563456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavioral disorders and substance abuse in adolescents with mental retardation].
    Papachristou E; Anagnostopoulos D
    Psychiatriki; 2014; 25(2):139-50. PubMed ID: 25035183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiology of Adolescent Substance Use Disorders.
    Sharma A; Morrow JD
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):367-75. PubMed ID: 27338961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of risk and protective factors of substance use and problem use in emerging adulthood.
    Stone AL; Becker LG; Huber AM; Catalano RF
    Addict Behav; 2012 Jul; 37(7):747-75. PubMed ID: 22445418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROSPER delivery of universal preventive interventions with young adolescents: long-term effects on emerging adult substance misuse and associated risk behaviors.
    Spoth R; Redmond C; Shin C; Greenberg MT; Feinberg ME; Trudeau L
    Psychol Med; 2017 Oct; 47(13):2246-2259. PubMed ID: 28399955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent substance misuse: neurobiology and evidence-based interventions.
    Newton NC; O'Leary-Barrett M; Conrod PJ
    Curr Top Behav Neurosci; 2013; 13():685-708. PubMed ID: 22057622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental sources of variation in liability to adolescent substance use disorders.
    Dawes MA; Antelman SM; Vanyukov MM; Giancola P; Tarter RE; Susman EJ; Mezzich A; Clark DB
    Drug Alcohol Depend; 2000 Dec; 61(1):3-14. PubMed ID: 11064179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intervening early to reduce developmentally harmful substance use among youth populations.
    Lubman DI; Hides L; Yücel M; Toumbourou JW
    Med J Aust; 2007 Oct; 187(S7):S22-5. PubMed ID: 17908020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-national comparison of risk and protective factors for adolescent substance use: the United States and Australia.
    Beyers JM; Toumbourou JW; Catalano RF; Arthur MW; Hawkins JD
    J Adolesc Health; 2004 Jul; 35(1):3-16. PubMed ID: 15193569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weighing the Risk: Developmental Pathways and Processes Underlying Obesity to Substance Use in Adolescence.
    Lanza HI
    J Res Adolesc; 2022 Mar; 32(1):337-354. PubMed ID: 34490962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.